Magle Chemoswed Holding AB (publ) (STO:MAGLE)

Sweden flag Sweden · Delayed Price · Currency is SEK
4.560
+0.080 (1.79%)
Apr 29, 2026, 9:00 AM CET
-83.94%
Market Cap 92.51M
Revenue (ttm) 287.55M
Net Income (ttm) -159.89M
Shares Out 20.65M
EPS (ttm) -7.74
PE Ratio n/a
Forward PE 3.20
Dividend n/a
Ex-Dividend Date n/a
Volume 219
Average Volume 9,973
Open 4.560
Previous Close 4.480
Day's Range 4.560 - 4.560
52-Week Range 3.680 - 30.000
Beta 0.47
RSI 35.64
Earnings Date Jun 9, 2026

About STO:MAGLE

Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; and benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson’s disease. The company also offers EmboCept S, a microsphere-based medical dev... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1944
Employees 140
Stock Exchange Nasdaq Stockholm
Ticker Symbol MAGLE
Full Company Profile

Financial Performance

Financial Statements